The present invention relates to the field of preventive and therapeutic medicine, in particular
to peptide formulations. Provided is a p H-buffered aqueous formulation comprising
oxytocin, vasopressin or an analogue thereof and at least one non-toxic source of divalent
metal ions in a concentration of at least 2 m M, and the use of the formulation for the
manufacture of a medicament for therapeutic and/or prophylactic treatments. Also provided is
a method for treating or preventing haemorrhage in a subject in need thereof, comprising
administering to said subject an effective dosage amount of an oxytocin formulation
according to the invention. Further provided is a method for treating or preventing diabetes
insipidus or vasodilatory shock in a subject in need thereof, comprising administering to said
subject an effective dosage amount of a vasopressin formulation according to the invention
